Mithra Pharmaceuticals SA (STU:1TM)
€ 0.18 0 (0%) Market Cap: 12.04 Mil Enterprise Value: 196.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Half Year 2020 Mithra Pharmaceuticals SA Earnings Call Transcript

Sep 24, 2020 / 01:00PM GMT
Release Date Price: €16.12 (-5.62%)
Operator

Hello, and welcome to the Mithra Half Year Results 2020. My name is Josh, and I'll be your coordinator for today's event. Please note that this conference is being recorded. (Operator Instructions)

I will now hand you over to your host, Alexandra Deschner, to begin today's conference. Thank you.

Alexandra Deschner
Mithra Pharmaceuticals SA - IR Officer

Thank you very much, Josh, and welcome to Mithra's half year results webcast for analysts and investors. My name is Alexandra Deschner, Investor Relations Officer. This recorded webcast is accessible on the Mithra's homepage and will be available later today for replay.

I'd like to remind you that this webcast is covered by the safe harbor statement on Page 2 of the presentation. Forward-looking statements may be presented during our call that include statements about our future expectations, development pipeline, time lines, potential success of our product candidates, financial forecast and upcoming milestones. Actual results may vary, and Mithra is under no obligation to update these

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot